DCGI approves AstraZeneca’s Lynparza for adjuvant treatment of patients with high-risk early breast cancer Read more
CORBEVAX gets EUA from Health Ministry as heterologous COVID-19 booster shot for 18 years and above Read more
SII seeks market authorisation from DCGI for India’s first qHPV vaccine against cervical cancer Read more
Unable to sell Sputnik Light stock, Stelis Biopharma requests PM Modi for procurement of jabs Read more